Mark J Rosenblum insider trades

Open-market stock purchases and sales by Mark J Rosenblum, Chief Financial Officer at Decoy Therapeutics Inc, from SEC Form 4 filings since Oct 14, 2010.

Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Aug 31, 2026DCOY Decoy Therapeutics IncBought (not open market)—
Nov 20, 2025SLRX Salarius Pharmaceuticals, IncBought$16K

Companies traded

  • DCOY Decoy Therapeutics Inc: other filings, last Aug 31, 2026
  • SLRX Salarius Pharmaceuticals, Inc: 6 buys, last Nov 20, 2025
  • ADXS Advaxis, Inc: 2 buys, last Jan 31, 2014

Get free alerts when Mark J Rosenblum files a new trade →